Summary
This large cross-ancestry genetic study identified 15 novel and established risk loci for amyotrophic lateral sclerosis through integrated GWAS, whole-genome sequencing, and cortex eQTL analysis. The findings reveal locus-specific genetic architectures involving rare variants, tandem repeats, and regulatory mechanisms, with evidence supporting a causal role for elevated cholesterol levels and highlighting perturbations in vesicle-mediated transport and autophagy as central disease mechanisms.
UK applicability
This fundamental genetic discovery has potential implications for UK-based ALS research and future therapeutic development, though the study itself does not address UK-specific environmental or clinical factors. UK clinicians and researchers may benefit from these validated genetic risk markers in patient stratification and precision medicine approaches.
Key measures
Genetic risk loci identified; association signals in rare variants and short tandem repeats; regulatory effects via eQTL; regional brain and cell-type enrichment patterns; Mendelian randomisation estimates for cholesterol causality
Outcomes reported
The study identified 15 genetic risk loci for amyotrophic lateral sclerosis through genome-wide association analysis in 29,612 patients and 122,656 controls, combined with whole-genome sequencing and expression analysis. Mendelian randomisation indicated a causal role for high cholesterol levels as an environmental risk factor.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.